NEO – Neogenomics Inc.

NeoGenomics, Inc.

NEO

$9.55

Name : NeoGenomics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $1,228,674,432.00

EPSttm : -0.62

NeoGenomics, Inc.

$9.55

0.10%

$0.01

Float Short %

3.81

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.01

EPS Last/This Y

0.79

EPS This/Next Y

0.18

Price

9.55

Target Price

Analyst Recom

1.67

Performance Q

-31.69

Relative Volume

0.96

Beta

1.49

Ticker: NEO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	NEO	9.94	0.13	0.26	21987
2025-03-21	NEO	9.85	0.13	0.53	21970
2025-03-24	NEO	10.16	0.15	0.01	15630
2025-03-25	NEO	9.97	0.15	1.06	16040
2025-03-26	NEO	9.42	0.15	0.00	16087
2025-03-27	NEO	9.48	0.15	0.00	16177
2025-03-28	NEO	9.62	0.15	88.33	16121
2025-03-31	NEO	9.49	0.16	0.00	16252
2025-04-01	NEO	9.35	0.16	0.00	16275
2025-04-02	NEO	9.41	0.16	0.00	16363
2025-04-03	NEO	8.74	0.15	0.06	16564
2025-04-04	NEO	8.77	0.14	0.09	16678
2025-04-07	NEO	8.84	0.14	0.26	16830
2025-04-08	NEO	8.19	0.14	0.30	16805
2025-04-09	NEO	9.11	0.14	0.07	16826
2025-04-10	NEO	8.88	0.14	0.20	16813
2025-04-11	NEO	9.32	0.14	0.02	16815
2025-04-14	NEO	9.72	0.14	0.03	16957
2025-04-15	NEO	9.51	0.14	10.50	17271
2025-04-16	NEO	9.55	0.13	18.65	17239
2025-04-17	NEO	9.55	0.19	0.01	18044
2025-04-18	NEO	9.55	0.19	0.01	18044
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	NEO	9.93	59.1	-	0.16
2025-03-21	NEO	9.85	59.1	-	0.16
2025-03-24	NEO	10.16	59.1	-	0.16
2025-03-25	NEO	9.96	59.1	-	0.16
2025-03-26	NEO	9.41	59.1	-	0.16
2025-03-27	NEO	9.49	59.1	-	0.16
2025-03-28	NEO	9.62	59.1	-	0.16
2025-03-31	NEO	9.49	59.1	-	0.16
2025-04-01	NEO	9.35	59.1	-	0.16
2025-04-02	NEO	9.42	66.7	-	0.16
2025-04-03	NEO	8.72	66.7	-	0.16
2025-04-04	NEO	8.78	54.2	-	0.16
2025-04-07	NEO	8.84	54.2	-	0.16
2025-04-08	NEO	8.20	54.2	-	0.16
2025-04-09	NEO	9.12	54.2	-	0.16
2025-04-10	NEO	8.89	54.2	-	0.16
2025-04-11	NEO	9.32	54.2	-	0.16
2025-04-14	NEO	9.72	54.2	-	0.16
2025-04-15	NEO	9.50	54.2	-	0.16
2025-04-16	NEO	9.55	54.2	-	0.16
2025-04-17	NEO	9.55	50.0	-	0.17
2025-04-18	NEO	9.55	50.0	-	0.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	NEO	-0.33	-1.92	2.75
2025-03-21	NEO	-0.33	-1.92	2.75
2025-03-24	NEO	-0.33	-1.97	2.75
2025-03-25	NEO	-0.33	-1.97	2.75
2025-03-26	NEO	-0.33	-1.97	3.33
2025-03-27	NEO	-0.33	-1.97	3.33
2025-03-28	NEO	-0.33	-1.97	3.33
2025-03-31	NEO	-0.33	1.46	3.33
2025-04-01	NEO	-0.33	1.46	3.33
2025-04-02	NEO	-0.33	1.46	3.33
2025-04-03	NEO	-0.33	1.46	3.33
2025-04-04	NEO	-0.33	1.46	3.33
2025-04-07	NEO	-0.33	1.46	3.33
2025-04-08	NEO	-0.33	1.46	3.33
2025-04-09	NEO	-0.33	1.46	3.33
2025-04-10	NEO	-0.33	1.46	3.81
2025-04-11	NEO	-0.33	1.46	3.81
2025-04-14	NEO	-0.33	1.44	3.81
2025-04-15	NEO	-0.33	1.44	3.81
2025-04-16	NEO	-0.33	1.44	3.81
2025-04-17	NEO	-0.33	1.44	3.81
2025-04-18	NEO	-0.33	1.44	3.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-0.33

Institutional Transactions

1.44

Beta

1.49

Average Sales Estimate Current Quarter

171

Average Sales Estimate Next Quarter

182

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.5

Max Drawdown 5-Year %

-89.2

Target Price

P/E

Forward P/E

27.11

PEG

P/S

1.86

P/B

1.36

P/Free Cash Flow

EPS

-0.62

Average EPS Est. Cur. Y

0.17

EPS Next Y. (Est.)

0.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.92

Relative Volume

0.96

Return on Equity vs Sector %

-28.7

Return on Equity vs Industry %

-19.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2200

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

stock quote shares NEO – Neogenomics Inc. Stock Price stock today

news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – Neogenomics Inc. yahoo finance google finance

stock history NEO – Neogenomics Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

NEO – NeoGenomics, Inc.

Name : NeoGenomics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $0.0000

EPSttm :

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=NEO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

3.81

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

0.01

EPS Last/This Y

0.79

EPS This/Next Y

0.18

Price

9.55

Target Price

Analyst Recom

1.67

Performance Q

-31.69

Relative Volume

0.96

Beta

1.49

Ticker: NEO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	NEO	9.94	0.13	0.26	21987
2025-03-21	NEO	9.85	0.13	0.53	21970
2025-03-24	NEO	10.16	0.15	0.01	15630
2025-03-25	NEO	9.97	0.15	1.06	16040
2025-03-26	NEO	9.42	0.15	0.00	16087
2025-03-27	NEO	9.48	0.15	0.00	16177
2025-03-28	NEO	9.62	0.15	88.33	16121
2025-03-31	NEO	9.49	0.16	0.00	16252
2025-04-01	NEO	9.35	0.16	0.00	16275
2025-04-02	NEO	9.41	0.16	0.00	16363
2025-04-03	NEO	8.74	0.15	0.06	16564
2025-04-04	NEO	8.77	0.14	0.09	16678
2025-04-07	NEO	8.84	0.14	0.26	16830
2025-04-08	NEO	8.19	0.14	0.30	16805
2025-04-09	NEO	9.11	0.14	0.07	16826
2025-04-10	NEO	8.88	0.14	0.20	16813
2025-04-11	NEO	9.32	0.14	0.02	16815
2025-04-14	NEO	9.72	0.14	0.03	16957
2025-04-15	NEO	9.51	0.14	10.50	17271
2025-04-16	NEO	9.55	0.13	18.65	17239
2025-04-17	NEO	9.55	0.19	0.01	18044
2025-04-18	NEO	9.55	0.19	0.01	18044
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	NEO	9.93	59.1	-	0.16
2025-03-21	NEO	9.85	59.1	-	0.16
2025-03-24	NEO	10.16	59.1	-	0.16
2025-03-25	NEO	9.96	59.1	-	0.16
2025-03-26	NEO	9.41	59.1	-	0.16
2025-03-27	NEO	9.49	59.1	-	0.16
2025-03-28	NEO	9.62	59.1	-	0.16
2025-03-31	NEO	9.49	59.1	-	0.16
2025-04-01	NEO	9.35	59.1	-	0.16
2025-04-02	NEO	9.42	66.7	-	0.16
2025-04-03	NEO	8.72	66.7	-	0.16
2025-04-04	NEO	8.78	54.2	-	0.16
2025-04-07	NEO	8.84	54.2	-	0.16
2025-04-08	NEO	8.20	54.2	-	0.16
2025-04-09	NEO	9.12	54.2	-	0.16
2025-04-10	NEO	8.89	54.2	-	0.16
2025-04-11	NEO	9.32	54.2	-	0.16
2025-04-14	NEO	9.72	54.2	-	0.16
2025-04-15	NEO	9.50	54.2	-	0.16
2025-04-16	NEO	9.55	54.2	-	0.16
2025-04-17	NEO	9.55	50.0	-	0.17
2025-04-18	NEO	9.55	50.0	-	0.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	NEO	-0.33	-1.92	2.75
2025-03-21	NEO	-0.33	-1.92	2.75
2025-03-24	NEO	-0.33	-1.97	2.75
2025-03-25	NEO	-0.33	-1.97	2.75
2025-03-26	NEO	-0.33	-1.97	3.33
2025-03-27	NEO	-0.33	-1.97	3.33
2025-03-28	NEO	-0.33	-1.97	3.33
2025-03-31	NEO	-0.33	1.46	3.33
2025-04-01	NEO	-0.33	1.46	3.33
2025-04-02	NEO	-0.33	1.46	3.33
2025-04-03	NEO	-0.33	1.46	3.33
2025-04-04	NEO	-0.33	1.46	3.33
2025-04-07	NEO	-0.33	1.46	3.33
2025-04-08	NEO	-0.33	1.46	3.33
2025-04-09	NEO	-0.33	1.46	3.33
2025-04-10	NEO	-0.33	1.46	3.81
2025-04-11	NEO	-0.33	1.46	3.81
2025-04-14	NEO	-0.33	1.44	3.81
2025-04-15	NEO	-0.33	1.44	3.81
2025-04-16	NEO	-0.33	1.44	3.81
2025-04-17	NEO	-0.33	1.44	3.81
2025-04-18	NEO	-0.33	1.44	3.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-0.33

Institutional Transactions

1.44

Beta

1.49

Average Sales Estimate Current Quarter

171

Average Sales Estimate Next Quarter

182

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.5

Max Drawdown 5-Year %

-89.2

Target Price

P/E

Forward P/E

27.11

PEG

P/S

1.86

P/B

1.36

P/Free Cash Flow

EPS

-0.62

Average EPS Est. Cur. Y

0.17

EPS Next Y. (Est.)

0.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.92

Relative Volume

0.96

Return on Equity vs Sector %

-28.7

Return on Equity vs Industry %

-19.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2200

stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today

news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance

stock history NEO – NeoGenomics, Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

NEO – Neogenomics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NEO – NeoGenomics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y